Tag: Jacqueline Shea

Human fingers are using medicine for genetic editing. Genetically modified DNA, blue background concept in invention. Development of genetically modified human genesPharma & Biotech

Plymouth Meeting-based Inovio Delays FDA Approval Plans for Experimental DNA Drug

Plymouth Meeting-based Inovio is delaying plans to seek Food and Drug Administration approval for its experimental DNA medicine as a treatment for recurrent respiratory…

Inovio Pharmaceuticals buildingPharma & Biotech

Plymouth Meeting-based Inovio Expects to Raise $36M Following “Transformational” 2023

Plymouth Meeting-based Inovio Pharmaceuticals is expecting to raise $36 million through a stock offering this week, writes John George for the Philadelphia Business Journal…

A woman working in a lab.Pharma & Biotech

Plymouth Meeting's Inovio on Track to Launch First DNA Medicine in U.S.

Plymouth Meeting-based Inovio Pharmaceuticals is on the right track to launch its first product which would also be the first DNA medicine in the…

Jacqueline Shea headshotPharma & Biotech

Plymouth Meeting’s Inovio Shares Spike After Positive FDA Reception on Groundbreaking Treatment

Plymouth Meeting biotech company Inovio’s innovations are paying off. Amid positive feedback from the FDA on an experimental respiratory disease therapy, the Montgomery County…

child getting a vaccinePharma & Biotech

Inovio Pulls Development of Two Vaccines; Stock-Price Health Weakens in Response

Plymouth Meeting pharmaceutical company Inovio has discontinued development of two vaccines, based on evidence of their ineffectiveness. As a result, its stock prices showed a…

J. Joseph Kim CEOPharma & Biotech

Plymouth Meeting-based Inovio Replaces CEO, Switches Focus from COVID-19 Vaccine to Developing Booster

Plymouth Meeting-based Inovio has replaced co-founder J. Joseph Kim as CEO and announced that it will shift its focus from developing a COVID…